 | Up a level |
Journal Article
Reinwald, M., Spiess, B., Heinz, W. J., Cornely, O. A., Schwerdtfeger, R., Hahn, J., Krause, S. W., Bertz, H., Reuter, S., Wolf, H. H., Claus, B., Boch, T., Hofmann, W. -K and Buchheidt, D. (2014). Aspergillus specific PCR of specimens more adequately representing the infectious localization such as bronchoalveolar lavage, cerebrospinal fluid or tissue/effusion samples are superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis. Oncol. Res. Treat., 37. S. 93 - 94. BASEL: KARGER. ISSN 2296-5262
Spiess, B., Reinwald, M., Postina, P., Cornely, O. A., Heussel, C. -P, Heinz, W., Lehrnbecher, T., Bertz, H., Hahn, J., Janssen, G., Claus, B., Lauten, M., Egerer, G., Behrends, U., Nathrath, M., Wolf, H. -H, Gruhn, B., Frickhofen, N., Woessmann, W., Will, S., Merker, N., Boch, T., Hofmann, W. -K and Buchheidt, D. (2014). Detection of fungal DNA in Aspergillus PCR-negative tissue biopsy samples from immunocompromised hematological patients using DNA microarray technology improves diagnosis of invasive fungal infections (IFI). Oncol. Res. Treat., 37. S. 93 - 94. BASEL: KARGER. ISSN 2296-5262
Spiess, B., Skladny, J., Boch, T., Cornely, O. A., Steinmann, J., Rath, P. -M, Miethke, T., Dietz, A., Merker, N., Hofmann, W. -K and Buchheidt, D. (2018). Analysis of the diagnostic performance of the AsperGenius (R) system in clinical samples of immunocompromised patients and in BAL fluid spiked with serially diluted Aspergillus fumigatus conidia. Oncol. Res. Treat., 41. S. 207 - 208. BASEL: KARGER. ISSN 2296-5262